The clinical spectrum associated with ATP1A2 variants in Chinese pediatric patients
Brain and Development · 2023
DOI: 10.1016/j.braindev.2023.04.003 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Development, 2023. Verfasst von Lifang Dai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, 100045, China. Hauptthemen laut MEDLINE: Seizures, Febrile, Migraine with Aura, Drug Resistant Epilepsy. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 24 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, 100045, China.
- Department of Neurology, Beijing Children's Hospital, Capital Medical University, National Center for Children's Health, 100045, China; Department of Neurology, Baoding Children's Hospital, Baoding, Hebei 071000, China.…
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Dai, L., Ding, C., Tian, X., Liu, M., Ma, Y., Chen, C., Ren, X., & Li, H. (2023). The clinical spectrum associated with ATP1A2 variants in Chinese pediatric patients. Brain and Development. https://doi.org/10.1016/j.braindev.2023.04.003
Vancouver
Dai L, Ding C, Tian X, Liu M, Ma Y, Chen C, et al. The clinical spectrum associated with ATP1A2 variants in Chinese pediatric patients. Brain and Development. 2023. doi:10.1016/j.braindev.2023.04.003
BibTeX
@article{Dai2023,
author = {Dai, Lifang and Ding, Changhong and Tian, Xiaojuan and Liu, Ming and Ma, Yuping and Chen, Chunhong and Ren, Xiaotun and Li, Hua},
title = {The clinical spectrum associated with ATP1A2 variants in Chinese pediatric patients},
journal = {Brain and Development},
year = {2023},
doi = {10.1016/j.braindev.2023.04.003}
}
EUVIMED